...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution
Reply New Message
Prev Message Back To Forum Threaded View Next Message

imo I believe this raise is a gift of sorts - we will see if anything happens prior to Christmas/early Jan max.

If nothing happens as per usual - it will be more head scratching & wondering just WTFrick this CEO is trying to prove!!

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply